₹31.56
▲ +0.02 +0.06%
17 Jul 2026
BSE Listed
GSM 0 · ESM 1Zenlabs Ethica Limited (530697)
Volume: 61Avg Vol 1W: 150Avg Vol 1M: 1,65552W Range:₹16.5₹39.99
Key Ratios
Checked just nowMarket Cap₹21 Cr
Current Price₹31.56
Previous Close₹31.54
High / Low (52w)₹39.99 / ₹16.5
Volume61
Avg Vol (1W)150
Avg Vol (1M)1,655
Stock P/E1,052
Book Value₹13.07
Dividend Yield0%
ROE23.49%
ROA-5.21%
Revenue (TTM)—
Revenue Growth—
Profit Margin-413.47%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.03
P/B2.41
Debt / Equity1.34
50 DMA₹33.14
200 DMA₹26.13
Day change+0.06%
SurveillanceGSM 0 · ESM 1 (as of 2026-07-17)
Price Chart
₹31.56▼ 9.31% · 1Y
2025-07-172026-07-17
20-day avg volume: 2K shares
Pros
- Healthy return on equity of 23.5%.
- Company is almost debt-free.
Cons
- Revenue fell 13% YoY.
- Stock trades at a high P/E of 1052.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹12 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-2 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹72 Cr | ₹67 Cr | ₹60 Cr | ₹57 Cr | ₹69 Cr | ₹67 Cr | ₹59 Cr | ₹51 Cr |
| EBITDA | ₹2 Cr | ₹2 Cr | ₹-1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹-1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | 1.88 | 1.94 | -1.13 | 1.18 | 1.2 | 0.75 | 0.65 | 0.41 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹30 Cr | ₹35 Cr | ₹34 Cr | ₹32 Cr | ₹38 Cr | ₹43 Cr | ₹40 Cr | ₹41 Cr |
| Total Liabilities | ₹23 Cr | ₹27 Cr | ₹27 Cr | ₹24 Cr | ₹29 Cr | ₹34 Cr | ₹30 Cr | ₹30 Cr |
| Equity | ₹7 Cr | ₹8 Cr | ₹7 Cr | ₹9 Cr | ₹9 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹-8 Cr | ₹0 Cr | ₹2 Cr | ₹-9 Cr | ₹4 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr |
| Financing | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹8 Cr | ₹-3 Cr |
| Free Cash Flow | ₹-8 Cr | ₹0 Cr | ₹0 Cr | ₹-9 Cr | ₹4 Cr |
Shareholding
Promoter 52.96% Institutions 0% Public 47.04%
Efficiency & Working Capital
ROCE5.2%
Interest Coverage1.5
Dividend Payout—
Debtor Days139 d
Inventory Days93 d
Payable Days101 d
Cash Conversion Cycle130 d
Working Capital Days232 d
Shareholding Details
As of 2026-03-31
Promoter53%
FII0%
DII0%
Institutions0%
Public47%
Promoter Pledge0%
No. of Shareholders2,756
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 59.1% | 59.1% | 59.1% | 53% | 53% | 53% | 53% | 53% | 53% | 53% | 53% | 53% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 40.9% | 40.9% | 40.9% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,025 | 2,159 | 2,199 | 2,482 | 2,462 | 2,635 | 2,630 | 2,663 | 2,648 | 2,712 | 2,774 | 2,756 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Preet Remedies Limited | Shareholding of Promoter and Promoter Group | 26.6% | 17,30,455 |
| Sanjay Dhir | Shareholding of Promoter and Promoter Group | 13.2% | 8,57,728 |
| Sanjeev Kumar Singal | Shareholding of Promoter and Promoter Group | 13.2% | 8,57,574 |
| Hitesh Popatlal Oswal | Public Shareholding | 6.8% | 4,41,962 |
| B S Mallikarjuna | Public Shareholding | 2.1% | 1,39,385 |
| Bhasakarrai Kanyalal Bhatt | Public Shareholding | 1.9% | 1,20,945 |
| Himjyoti | Shareholding of Promoter and Promoter Group | 0% | 1,000 |
| Harjinder Kaur | Shareholding of Promoter and Promoter Group | 0% | 1,000 |
| Daman Singhal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kulwant Kaur | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Sanjeev Kumar Singal | 0 | 0% | 2026-03-31 |
| Sanjay Dhir | 0 | 0% | 2026-03-31 |
| Himjyoti | 0 | 0% | 2026-03-31 |
| Harjinder Kaur | 0 | 0% | 2026-03-31 |
| Daman Singhal | 0 | 0% | 2026-03-31 |
| Kulwant Kaur | 0 | 0% | 2026-03-31 |
| Preet Remedies Limited | 0 | 0% | 2026-03-31 |
| Hitesh Popatlal Oswal | 0 | 0% | 2026-03-31 |
| Bhasakarrai Kanyalal Bhatt | 0 | 0% | 2026-03-31 |
| B S Mallikarjuna | 0 | 0% | 2026-03-31 |
| Sanjeev Kumar Singal | 0 | 0% | 2025-12-31 |
| Sanjay Dhir | 0 | 0% | 2025-12-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sanjay Dhir | WTD & Executive Director | 2025 |
| Sanjeev Kumar | ED / MD / CEO / Promoter | 2025 |
| Him Jyoti | Non Executive Director | 2025 |
| Kuldeep Singh | Independent Non Exe. Director | 2025 |
| Anurag Malhotra | Independent Non Exe. Director | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 20 | 7 | 7 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 2 | 41 | 43 |
| 2025 | 0 | 0 | 0 | 2 | 40 | 42 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
Substantial Acquisitions (SAST)
5 disclosure(s)
Off Market22/03/2024 · 4,00,000
Off Market22/03/2024 · 4,00,000
-11/08/2021 · 3,59,000
Inter-se Transfer11/08/2021 · 1,79,500
Inter-se Transfer11/08/2021 · 1,79,500
Company Information
🌐 www.zenlabsethica.com ↗
📍 Plot No 194-195 3rd Flr Pha-II, Industrial Area Ram Darbar, Chandigarh, Chandigarh, 160002
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Ace Engitech LimitedYork Exports Ltd.Supreme Holdings & HospitalityPithampur Poly Products LimitedLykis LimitedPrime Property DevelopmenRaj Rayon IndustriesGowra Leasing & Finance LimitedJagan Lamps Ltd.Asit C.Mehta Financial SeEncode Packaging India LimitedSuper Bakers (India) Ltd.All “53” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search